Study Finds Laughing Gas Can Provide Quick Relief from Depression

New Research on Nitrous Oxide and Depression Relief

A study conducted by researchers from the University of Birmingham and the University of Oxford has discovered that controlled doses of laughing gas, or nitrous oxide, can actually offer rapid relief from depression.

This approach appears to be effective over extended periods when used in repeated doses, particularly for individuals battling major depressive disorder (MDD) and treatment-resistant depression (TRD). These are among the hardest cases to treat.

“It’s an exciting outcome,” says psychiatrist Steven Marwaha from the University of Birmingham. “This group has often felt hopeless about recovery.”

The findings point to the urgent need for innovative treatments that can work alongside existing care options. Further evidence is required to explore how this method can best aid those living with severe depression.

The research team assessed seven clinical trials involving 247 participants and outlined additional future trial proposals as well.

During the trials, participants inhaled nitrous oxide at either 50 percent or 25 percent concentrations. The effects were compared with a placebo group.

Generally, the 50 percent concentration was more effective at alleviating symptoms of depression, though it often came with side effects like nausea, headaches, and feelings of dissociation.

Interestingly, the researchers noted that depressive symptoms could diminish within just two hours after inhalation; however, this relief was short-lived, with symptoms usually resurging within a week unless another dose was administered.

“This study presents solid evidence that nitrous oxide has potential for providing swift and clinically meaningful short-term improvements in patients facing severe depression,” explains clinical psychologist Kiranpreet Gill from the University of Birmingham.

While more comprehensive research is essential, the scientists speculate that nitrous oxide’s effects might be linked to its calming impact on the glutamatergic system, which is crucial in the nervous system and is often associated with depression.

Nitrous oxide is also known to enhance blood flow, potentially aiding in the circulation of gases, waste, and nutrients in the brain. As researchers gain more insight into this mechanism, treatment could be personalized for individual patients.

One thing is clear: there is a pressing need for new treatment options. This study underscores the growing challenge of depression, now the leading cause of disability worldwide, impacting more than 300 million individuals.

“Our findings indicate that nitrous oxide could be integral to a new wave of rapid-acting depression treatments,” Gill notes.

Significantly, this paves the way for future trials to explore repeated and carefully managed dosing regimens to clarify how to implement this treatment effectively for patients who do not respond to standard interventions.